-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"Involution" has become the norm in the competition for domestic innovative drug talents for a long time in the past
.
According to the "2022 Talent Market Insights and Salary Guide" issued by Career International, the parent company of Yimai Tongdao, in 2021, the salary of innovative drug talents will continue to rise.
The increase has reached 30%-40%, and the increase in job-hopping has exceeded the normal range, and 50% or even doubling is normal
.
The salaries of popular positions such as gene therapy CSO and cell therapy CTO have reached 2 million to 3 million yuan
In fact, from the 2015 drug policy reform, the domestic pharmaceutical industry has been upgraded from generic drugs to innovative drugs.
With the support of national policies and capital, China's innovative drugs have entered the fast lane, and the prosperity has also promoted the continued strong demand for talents
.
But at the same time, the development time of domestic innovative drugs is still short, and the time required for talent training and growth is not much, and the supply is "stretched"
01.
Lack of talent, what is missing?
"Talent" has become a difficult problem for innovative pharmaceutical companies.
On the surface, the talent gap caused by industrial prosperity is constantly expanding, but on a deeper level, it is a huge challenge brought by the talent construction of China's innovative drug ecosystem
.
In Wang Kuifeng's view, middle-level backbones are undoubtedly the most scarce resources for innovative pharmaceutical companies
02.
To attract, how to find the right person?
The first step in building a team is to recruit talents, but under the premise that the supply is in short supply, the huge gap caused by the shortage of talents itself makes it quite challenging
.
According to statistics, from 2015 to 2020, the number of newly established biopharmaceutical companies reached 233,100
03.
Cultivation, how to retain people?
How to retain talents after attracting talents is another problem that innovative pharmaceutical companies need to solve
.
Tong Youzhi pointed out that each company faces many challenges in how to retain talents under the "involution" type of talent snatch.
04.
How to understand the spirit of innovative drugs?
Behind all the technical details will indeed point to a question of values.
Now, large pharmaceutical companies with mature talent training echelons have experienced the process of dying and dying in the early stage of development.
The reason why they can persevere is the persistence of long-term value
.
The same is true for talent
This is not only due to the blood connection of medical people, but also the real starting point and expectation of the "Innovator" column jointly established by a professional and vertical human resources platform such as Yimai Tongdao, and professional industry media such as E-pharmaceutical managers and Shenlanguan
.
With everyone's dedicated attention and in-depth participation in the industry, everyone will stand together firmly.
